ChemicalBook > CAS DataBase List > Naltrexone methylbromide

Naltrexone methylbromide

Product Name
Naltrexone methylbromide
CAS No.
73232-52-7
Chemical Name
Naltrexone methylbromide
Synonyms
MNTX;Moa-728;Relistor;Unii-rfo6il3D3m;Adamantane Impurity 52;Naltrexone methobromide;Methylnaltrexone bromide;Naltrexone methylbromide;Methyhaaltrexone broMide;N-Methyl Naltrexone BroMide
CBNumber
CB11105859
Molecular Formula
C21H26BrNO4
Formula Weight
436.35
MOL File
73232-52-7.mol
More
Less

Naltrexone methylbromide Property

Melting point:
237-239°C
storage temp. 
-20°C
solubility 
H2O: ≥5mg/mL
form 
powder
color 
white to beige
Stability:
Hygroscopic
More
Less

Safety

Hazard Codes 
T,N
Risk Statements 
25-50
Safety Statements 
45-61
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
RTECS 
QD0188550
HS Code 
2934990002
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H301Toxic if swalloed

H400Very toxic to aquatic life

Precautionary statements

P273Avoid release to the environment.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML0277
Product name
Methylnaltrexone bromide
Purity
≥97% (HPLC)
Packaging
5mg
Price
$110
Updated
2024/03/01
Sigma-Aldrich
Product number
1430735
Product name
Methylnaltrexone bromide
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
100mg
Price
$1940
Updated
2024/03/01
Cayman Chemical
Product number
24072
Product name
Methylnaltrexone (bromide)
Purity
≥95%
Packaging
1mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
24072
Product name
Methylnaltrexone (bromide)
Purity
≥95%
Packaging
5mg
Price
$100
Updated
2024/03/01
Sigma-Aldrich
Product number
SML0277
Product name
Methylnaltrexone bromide
Purity
≥97% (HPLC)
Packaging
25mg
Price
$600
Updated
2024/03/01
More
Less

Naltrexone methylbromide Chemical Properties,Usage,Production

Description

The widespread efficacy of opioids in treating patients with moderate to severe acute and chronic pain is often accompanied by untoward side effects. In particular, opioid-induced bowel dysfunction is one of the more common and debilitating consequences afflicting up to 50% of patients. To counteract the peripherally-mediated adverse effects, opioid antagonists such as naloxone, naltrexone, and nalmephene are sometimes prescribed. The latest market entry exploits a strategic modification of naltrexone to lower its lipid solubility and increase its polarity: quaternization of the amine of naltrexone by methylation (methyl bromide) prevents crossing of the blood–brain barrier thereby creating an effective peripheral antagonist. Despite a loss of potency upon methylation, methylnaltrexone antagonizes opioid binding at m-opioid receptors with an IC50 of 70 nM. Its affinity for k-opioid receptors is approximately eightfold less (IC50= 575 nM) with no significant binding to d-opioid, orphanin, or non-opioid receptors. Methylnaltrexone bromide has been approved for the treatment of opioid-induced constipation in patients with advanced illness receiving palliative care.Regarding metabolism, methylnaltrexone bromide is eliminated primarily as intact drug (85% based on administered radioactivity) by slightly more renal than hepatic clearance.
The most common adverse events were abdominal pain and flatulence followed by nausea, dizziness, and diarrhea.

Chemical Properties

Pale Pink Solid

Originator

University of Chicago (United States)

Uses

Methylnaltrexone bromide has been used as a drug to measure plasma protein binding (PPB), permeability (Pm) and the membrane coefficient (KIAM) for the prediction of blood brain barrier (BBB) penetration. It is also used as a mu-opioid receptor (MOR) antagonist to abrogate morphine tolerance and opioid-induced hyperalgesia (OIH).

Uses

A metabolite of Naltrexone (N285750). Methylnaltrexone (MNTX), a selective μ-opioid receptor antagonist, functions as a peripherally acting receptor antagonist in tissues of the gastrointestinal tract.

brand name

Relistor

General Description

Methylnaltrexone does not cross blood brain barrier and does not affect the opioid effects in the brain, such as analgesia. It is used to treat opioid-induced constipation (OIC).

Biochem/physiol Actions

Methylnaltrexone bromide is a narcotic antagonist. It is a peripheral mu-opiod receptor antagonist that cannot cross the blood-brain barrier. It reverses many opioid side-effects without interfering with pain relief.

Clinical Use

N-Methylnaltrexone is the polar derivative of naltrexone, which does not reach the central nervous system but can block intestinal opioid receptors. The compound is under development to counteract opioid induced bowel dysfunction such as constipation and megacolon .

Synthesis

The synthesis of methylnaltrexone bromide proceeds in a straightforward manner via the alkylation of naltrexone 90 in the following scheme. Naltrexone 90 was reacted with methyl bromide in 1-methyl-2-pyrrolidinone at 60 ??C. The resulting crude product was treated with sodium methoxide in methanol/ water at 55 ??C to remove any undesired phenolic (Oalkylated) side-products. The resulting crude sodium salt was treated with hydrobromic acid in methanol/water and upon crystallization gave methylnaltrexone bromide (XII) in 35% overall yield.

storage

Store at -20°C

Naltrexone methylbromide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Naltrexone methylbromide Suppliers

Jinan Sanyuan Chemical Co. LTD
Tel
13335164090
Fax
0531-58585914
Email
1660423085@qq.com
Country
China
ProdList
411
Advantage
58
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Fax
+86-571-82880190
Email
info@yuhaochemical.com
Country
China
ProdList
9387
Advantage
52
Nanjing Norris-Pharm Technology Co., Ltd
Tel
13901585132
Fax
+86-25-52131256
Email
799750417@qq.com
Country
China
ProdList
8878
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Moltt Biocem Co., Ltd.
Tel
+86-21-38682181 15900741819
Fax
+86-21-38682181
Country
China
ProdList
282
Advantage
55
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Chongqing Landtower Pharmaceutical Co., Ltd.
Tel
023-68980308
Fax
023-68980318
Email
business@cqlandtower.com
Country
China
ProdList
37
Advantage
55
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Artis Biotech Co. Ltd.
Tel
0575-18780151478 18582380095
Fax
0575-89298961
Email
sales@artisbio.com
Country
China
ProdList
3044
Advantage
58

73232-52-7, Naltrexone methylbromideRelated Search:


  • Naltrexone methobromide
  • Naltrexone methylbromide
  • Moa-728
  • Morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, bromide, (5alpha)-
  • Relistor
  • Unii-rfo6il3D3m
  • Methylnaltrexone bromide
  • (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium bromide
  • N-Methyl Naltrexone BroMide
  • (5α)-17-(CyclopropylMethyl)-4,5-epoxy-3,14-dihydroxy-17-Methyl-6-oxoMorphinaniuM BroMide
  • N-CyclopropylMethyl-noroxyMorphone MethobroMide
  • Methyhaaltrexone broMide
  • 17-(CyclopropylMethyl)-4,5-epoxy-3,14-dihydroxy-17-Methyl-6-oxoMorphinaniuM broMide
  • MNTX
  • Quaternary ammonium naltrexone
  • 17-(Cyclopropylmethyl)-4,5A-Epoxy-3,14-Dihydroxy-17-Methyl-6-Oxomorphinanium Bromide
  • Methylnaltrexone Peak Identification Mixture Cll
  • (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7-one,bromide
  • Methylnaltrexone iodide salt
  • N-Methyl Naltrexone Bromide (1.0mg/ml in DMSO)
  • Methylnaltrexone Bromide (1430735)
  • inhibit,Opioid Receptor,suppression,gastrointestinal,Methylnaltrexone bromide,blood-brain,tract,peripheral,barrier,analgesia,Inhibitor
  • Adamantane Impurity 52
  • 73232-52-7
  • C21H26NO4Br
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals